Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login


The Cancer Letter Inc.
PO Box 9905
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: Feb 12, 2016
ISSUE 6 - FEB. 12, 2016 PDF

Obama's $4.1 Trillion Budget Proposes Mandatory Funds for $1 Billion Moonshot

President Barack Obama Feb. 8 unveiled his budget proposal for the 2017 fiscal year—a $4.1 trillion spending blueprint that is unlikely to be passed by a Republican-controlled Congress.

The administration’s proposal appears to cut the NIH existing budget by $1 billion in discretionary funding and makes up the difference with mandatory funding.

In a joint snub, the House and Senate budget committees declined to hold a hearing for Shaun Donovan, the director of the Office of Management and Budget. The move marks the first time in 41 years that Congress has refused to review a president’s budget.


Conversation with The Cancer Letter

Sigal: FDA Should Consolidate Cancer Portfolio

President Barack Obama’s Feb. 8 budget request for fiscal year 2017 slates $75 million in additional funding for FDA for the creation of a virtual Oncology Center of Excellence.

The proposal is arguably the most tangible component of Vice President Joe Biden’s National Cancer Moonshot program, which aims to double progress in cancer research and drug development over the next five years.

    Slamming the Door - How Al Gilman Taught Texas a Lesson in Science

    Part III: 18,000 Bosses

    Between the fall of 2011 and the spring of 2012, I watched MD Anderson from afar, and I didn’t think about CPRIT at all.

    Friends who attended early meetings with Ronald DePinho soon after he became MD Anderson’s president said that he was literally grading presentations made to him by faculty members and administrators.

    “This was a C-,” he would say.

    It was difficult to get a B.

      In Brief
      • Miami Cancer Institute joins MSK Cancer Alliance

      • Ramalingam named deputy director of Winship Cancer Institute

      • David McConkey appointed director of Johns Hopkins Bladder Institute
      • Sylvester Comprehensive Cancer Center creates two endowed chairs

      • Pat Keel appointed CFO of St. Jude

      • Paul Vanveldhuisen named COO of The Emmes Corporation

      • American Urological Association, Urology Care Foundation and Chesapeake Urology Associates form partnership

      • Bonnie J. Addario Foundation launches second phase of crowdsourcing challenge

      • ESPN's Jimmy V Week for Cancer Research raises $3.2 million

      Drugs and Targets
      • FDA grants orphan designation to tazemetostat

      • PDS Biotechnology signs CRADA with NCI

      • FDA grants orphan designation to antifungal drug candidate CD101 IV


      Copyright (c) 2016 The Cancer Letter Inc.